Inogen CEO buys 1,500 shares at $5.33
Inogen’s CEO increased his direct holdings via a 1,500-share ESPP purchase under a Rule 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Inogen Inc (INGN) reports that CEO, President, and director Kevin Raymond Merrill Smith acquired 1,500 shares of common stock on September 1, 2026 through the company’s 2014 Employee Stock Purchase Plan at $5.33 per share. The filing shows he now directly owns 134,962 shares, with the transaction made under a Rule 10b5-1 trading plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 1,500 | $5.33 | $8K |
Footnotes (1)
- F1. Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
Key Figures
Key Terms
Employee Stock Purchase Plan financial
Rule 10b5-1 trading plan regulatory
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did INGN report for CEO Kevin Raymond Merrill Smith?
Was the recent INGN insider transaction made under a Rule 10b5-1 plan?
What type of transaction was reported for INGN’s CEO on the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.